March 13, 2026
Headlines

A Potential Challenger For AstraZeneca’s Blockbuster Lung Cancer Drug?

Sumain Faisal01 mins

AstraZeneca declined to comment without detailed clinical data on claims by Chinese makers of a competing experimental lung cancer drug.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News